Malherbe, Delphine C.
Kurup, Drishya http://orcid.org/0000-0002-3959-7700
Wirblich, Christoph
Ronk, Adam J.
Mire, Chad http://orcid.org/0000-0001-7596-1808
Kuzmina, Natalia
Shaik, Noor http://orcid.org/0000-0002-9336-4238
Periasamy, Sivakumar http://orcid.org/0000-0002-7038-5140
Hyde, Matthew A.
Williams, Julie M.
Shi, Pei-Yong http://orcid.org/0000-0001-5553-1616
Schnell, Matthias J. http://orcid.org/0000-0001-9040-9405
Bukreyev, Alexander http://orcid.org/0000-0002-0342-4824
Funding for this research was provided by:
Thomas Jefferson University
University of Texas Medical Branch at Galveston | Institute for Translational Sciences, University of Texas Medical Branch
Article History
Received: 11 February 2021
Accepted: 7 May 2021
First Online: 22 July 2021
Competing interests
: M. J. S., C. W., and D. K. are inventors on a current patent application “COVID-19 Vaccine”. The Shi laboratory has received unrelated funding support in sponsored research agreements from Pfizer and Gilead Sciences, Inc. No other authors declare any competing interests.